Boyu Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Abogen Biosciences (艾博生物)abogenbio.comAug 2021

Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.

BiotechDeep TechHealthtech

Bo Ying(Founder)

Co-investors5Y Capital Coatue Management Fuzhou Jiebao Rongan Venture Capital Qiming Venture Partners SoftBank Vision Fund GL Ventures +7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.